PRESS RELEASE published on 03/15/2024 at 14:46, 2 years 5 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a position of 3.46% in Ageas SA/NV. Details on ownership and dealing disclosed in Form 8.3 under Takeover Code Rule 8.3 The Vanguard Group, Inc. Form 8.3 Takeover Code Ownership Disclosure Ageas SA/NV
BRIEF published on 03/14/2024 at 14:24, 2 years 5 months ago The Vanguard Group, Inc. divulgue sa participation dans Ageas SA/NV Le Groupe Vanguard Ageas SA/NV Activités D'investissement Secteur Des Assurances Divulgation Des Enjeux
BRIEF published on 03/14/2024 at 14:24, 2 years 5 months ago The Vanguard Group, Inc. Discloses Stake in Ageas SA/NV The Vanguard Group Stake Disclosure Ageas SA/NV Investment Activities Insurance Sector
PRESS RELEASE published on 03/14/2024 at 14:19, 2 years 5 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.44% interest in Ageas SA/NV. Deals in ordinary securities were made at 39.53 EUR and 39.76 EUR per unit The Vanguard Group, Inc. Disclosure Ageas SA/NV Ordinary Securities Deals
BRIEF published on 03/13/2024 at 13:47, 2 years 5 months ago Vanguard Group annonce une participation dans Ageas SA/NV Achat D'actions Groupe D'avant-garde Ageas SA/NV Secteur Des Assurances Détention D'investissement
BRIEF published on 03/13/2024 at 13:47, 2 years 5 months ago Vanguard Group Announces Stake in Ageas SA/NV Stock Purchase Vanguard Group Ageas SA/NV Insurance Sector Investment Holding
PRESS RELEASE published on 03/13/2024 at 13:42, 2 years 5 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.44% stake in Ageas SA/NV. Dealings include purchase of 1,440 securities at 39.61 EUR per unit Securities Dealings The Vanguard Group Inc. Financial Disclosure Stake Disclosure Ageas SA/NV
BRIEF published on 03/12/2024 at 14:23, 2 years 5 months ago Vanguard Group dévoile sa participation dans Ageas SA/NV Actionnariat Divulgation Financière Groupe D'avant-garde Ageas SA/NV Dépôt Réglementaire
BRIEF published on 03/12/2024 at 14:23, 2 years 5 months ago Vanguard Group Discloses Stake in Ageas SA/NV Vanguard Group Financial Disclosure Shareholding Regulatory Filing Ageas SA/NV
PRESS RELEASE published on 03/12/2024 at 14:18, 2 years 5 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses 3.44% ownership in Ageas SA/NV. Details on the Form 8.3 filing revealed on 12-March-2024 The Vanguard Group, Inc. Form 8.3 Ownership Disclosure Financial Securities Ageas SA/NV
Published on 09/11/2026 at 04:00, 5 hours 18 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 53 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 58 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 18 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:05, 12 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 18 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 09:00, 18 minutes ago Mountain Alliance AG invests in Evolved Aerospace and expands its involvement in the European defence technology market
Published on 09/11/2026 at 07:00, 2 hours 18 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 18 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 18 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 48 minutes ago Availability of the 2026 Interim Financial Report
